Your Cart is Empty
Free Shipping On Retail Orders $149 And Over (Excludes Kaqun Water) | 90-Day Money Back Guarantee*
Free Shipping On Retail Orders $149 And Over (Excludes Kaqun Water) | 90-Day Money Back Guarantee*
METAL-FREE is a successful detox agent for heavy metals as shown by the following lab reports.
In this case report, the patient is a 49 year old female with amalgams removed in 1997. Shortly after this she was on a detoxification protocol using monthly I.V. DMPS, chlorella, cilantro and DMSA with antioxidant and mineral support. Another DMPS urine challenge in early June of 1999 showed mercury levels of 60 parts per billion on a reference range of 0 - 3. She had been unable to comply with her detox program because, she felt "bad all the time." Despite slightly elevated levels of arsenic and tin, the DMPS challenge did not indicate that any other metals were beyond the reference range.
We did a METAL-FREE challenge.
Stool levels for heavy metals is as follows:
| Metal | Pre-challenge result (ppm) | Post-challenge result (ppm) | Increase | Reference Range (ppm) |
| Mercury | 0.032 | 0.106 | 330% | < 0.05 |
| Antimony | 0.061 | 0.118 | 190% | < 0.08 |
| Arsenic | 3.87 | 6.6 | 170% | < 0.3 |
| Beryllium | < dl | 0.025 | 250% | < 0.009 |
| Copper | 40 | 300 | 750% | < 60 |
| Nickel | 8.3 | 18.6 | 220% | < 8 |
| Uranium | 0.066 | 0.302 | 450% | < 0.12 |
This patient shows elevated challenge levels of ALL the heavy metals shown. Huge amounts of arsenic! This arsenic did not show very elevated on the DMPS challenge.
It is noteworthy that throughout the study and thereafter, this patient reported no complaints or discomfort while doing the METAL-FREE treatment. Previously, she had stopped taking DMSA due to "feeling bad all the time." This may indicate that not only can METAL-FREE effectively remove heavy metals from the system, it is able to do so gently and without undue discomfort for the patient.
This case report is noteworthy for several reasons:
Comments will be approved before showing up.
On average 1 person in the United States dies from a blood clot every 6 minutes, which adds up to about 274 people per day.
Not surprisingly, the pharmaceutical industry has taken notice and the global market for anticoagulant drugs now exceeds 18.9 billion dollars, largely dominated by just a few stand-out drugs like Warfarin (aka Coumadin), Rivaroxaban (Xarelto), and Apixaban (Eliquis).
